Home » NovaBay to Receive Increase in Funding, Support From Alcon
NovaBay to Receive Increase in Funding, Support From Alcon
NovaBay Pharmaceuticals, Inc., a clinical stage biopharmaceutical company
creating a new class of anti-infectives for treating multi-drug resistant pathogens, announced Thursday that effective immediately, its partner, Alcon
Inc. has increased its on-going financial support of the company’s research
and development efforts by more than $2 million per year.
CNNMoney
CNNMoney
Upcoming Events
-
07May
-
14May
-
30May